Search research articles
Contact Us
Filters
Showing results (231-240 of 254) with videos related to
Page
of 26
Sort By:
Nature Medicine
|
October 7, 2008
Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis
Renate Kain, Markus Exner, Ricarda Brandes, et al.
Glycoconjugate Journal
|
December 18, 2008
The N-glycolyl form of mouse sialyl Lewis X is recognized by selectins but not by HECA-452 and FH6 antibodies that were raised against human cells
Junya Mitoma, Tatsuo Miyazaki, Mark Sutton-Smith, et al.
Thoracic Cancer
|
December 19, 2019
Phase II study of ramucirumab and docetaxel for previously treated non-small cell lung cancer patients with malignant pleural effusion: Protocol of PLEURAM study
Shinnosuke Takemoto, Minoru Fukuda, Hiroyuki Yamaguchi, et al.
Plos One
|
August 17, 2013
Pharmacological inhibition of polysialyltransferase ST8SiaII modulates tumour cell migration
Yousef M J Al-Saraireh, Mark Sutherland, Bradley R Springett, et al.
Journal of Thoracic Disease
|
October 29, 2025
A phase II clinical trial on the efficacy and safety of carboplatin plus nab-paclitaxel in chemotherapy-naive advanced or recurrent thymic epithelial tumors: protocol of Nab-TET
Fumiko Hayashi, Midori Matsuo, Shinnosuke Takemoto, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
August 27, 2019
Serum Antibody Against NY-ESO-1 and XAGE1 Antigens Potentially Predicts Clinical Responses to Anti-Programmed Cell Death-1 Therapy in NSCLC
Yoshihiro Ohue, Koji Kurose, Takahiro Karasaki, et al.
The Journal of Biological Chemistry
|
December 24, 2011
Identification of mono- and disulfated N-acetyl-lactosaminyl Oligosaccharide structures as epitopes specifically recognized by humanized monoclonal antibody HMOCC-1 raised against ovarian cancer
Toshiaki K Shibata, Fumiko Matsumura, Ping Wang, et al.
Journal of Clinical Medicine
|
September 28, 2021
Real-World Incidence of Febrile Neutropenia among Patients Treated with Single-Agent Amrubicin: Necessity of the Primary Prophylactic Administration of Granulocyte Colony-Stimulating Factor
Yosuke Dotsu, Hiroyuki Yamaguchi, Minoru Fukuda, et al.
JTO Clinical and Research Reports
|
December 4, 2023
A Phase 2 Single-Arm Study of Osimertinib for Radiotherapy-Naive Central Nervous System Metastasis NSCLC: Results for the First-Line Cohort of the OCEAN Study (LOGIK 1603/WJOG 9116L)
Kazushige Wakuda, Hiroyuki Yamaguchi, Hirotsugu Kenmotsu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
August 22, 2021
A Phase II Study of Osimertinib for Radiotherapy-Naive Central Nervous System Metastasis From NSCLC: Results for the T790M Cohort of the OCEAN Study (LOGIK1603/WJOG9116L)
Hiroyuki Yamaguchi, Kazushige Wakuda, Minoru Fukuda, et al.
Page
of 26
Search research articles
Search
Showing results (231-240 of 254) with videos related to
Sort By:
Page
of 26
Nature Medicine
|
October 7, 2008
Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis
Renate Kain, Markus Exner, Ricarda Brandes, et al.
Glycoconjugate Journal
|
December 18, 2008
The N-glycolyl form of mouse sialyl Lewis X is recognized by selectins but not by HECA-452 and FH6 antibodies that were raised against human cells
Junya Mitoma, Tatsuo Miyazaki, Mark Sutton-Smith, et al.
Thoracic Cancer
|
December 19, 2019
Phase II study of ramucirumab and docetaxel for previously treated non-small cell lung cancer patients with malignant pleural effusion: Protocol of PLEURAM study
Shinnosuke Takemoto, Minoru Fukuda, Hiroyuki Yamaguchi, et al.
Plos One
|
August 17, 2013
Pharmacological inhibition of polysialyltransferase ST8SiaII modulates tumour cell migration
Yousef M J Al-Saraireh, Mark Sutherland, Bradley R Springett, et al.
Journal of Thoracic Disease
|
October 29, 2025
A phase II clinical trial on the efficacy and safety of carboplatin plus nab-paclitaxel in chemotherapy-naive advanced or recurrent thymic epithelial tumors: protocol of Nab-TET
Fumiko Hayashi, Midori Matsuo, Shinnosuke Takemoto, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
August 27, 2019
Serum Antibody Against NY-ESO-1 and XAGE1 Antigens Potentially Predicts Clinical Responses to Anti-Programmed Cell Death-1 Therapy in NSCLC
Yoshihiro Ohue, Koji Kurose, Takahiro Karasaki, et al.
The Journal of Biological Chemistry
|
December 24, 2011
Identification of mono- and disulfated N-acetyl-lactosaminyl Oligosaccharide structures as epitopes specifically recognized by humanized monoclonal antibody HMOCC-1 raised against ovarian cancer
Toshiaki K Shibata, Fumiko Matsumura, Ping Wang, et al.
Journal of Clinical Medicine
|
September 28, 2021
Real-World Incidence of Febrile Neutropenia among Patients Treated with Single-Agent Amrubicin: Necessity of the Primary Prophylactic Administration of Granulocyte Colony-Stimulating Factor
Yosuke Dotsu, Hiroyuki Yamaguchi, Minoru Fukuda, et al.
JTO Clinical and Research Reports
|
December 4, 2023
A Phase 2 Single-Arm Study of Osimertinib for Radiotherapy-Naive Central Nervous System Metastasis NSCLC: Results for the First-Line Cohort of the OCEAN Study (LOGIK 1603/WJOG 9116L)
Kazushige Wakuda, Hiroyuki Yamaguchi, Hirotsugu Kenmotsu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
August 22, 2021
A Phase II Study of Osimertinib for Radiotherapy-Naive Central Nervous System Metastasis From NSCLC: Results for the T790M Cohort of the OCEAN Study (LOGIK1603/WJOG9116L)
Hiroyuki Yamaguchi, Kazushige Wakuda, Minoru Fukuda, et al.
Page
of 26